|
AU2015252518B2
(en)
|
2014-04-29 |
2019-11-14 |
Genequantum Healthcare (Suzhou) Co., Ltd. |
New stable antibody-drug conjugate, preparation method therefor, and use thereof
|
|
KR102726248B1
(ko)
|
2016-07-07 |
2024-11-05 |
더 보드 어브 트러스티스 어브 더 리랜드 스탠포드 주니어 유니버시티 |
항체-애쥬번트 접합체
|
|
AU2020241686A1
(en)
|
2019-03-15 |
2021-11-04 |
Bolt Biotherapeutics, Inc. |
Immunoconjugates targeting HER2
|
|
IL288485B2
(en)
*
|
2019-05-29 |
2026-04-01 |
Daiichi Sankyo Co Ltd |
Anti-TROP2 antibody conjugates - a drug for use in cancer treatment
|
|
US20230101266A1
(en)
*
|
2019-12-31 |
2023-03-30 |
Genequantum Healthcare (Suzhou) Co., Ltd. |
Anti-trop2 antibodies, antibody-drug conjugates, and application of the same
|
|
CN115803062B
(zh)
*
|
2020-06-03 |
2025-09-09 |
博泰康医药公司 |
滋养层细胞表面抗原2(trop-2)抗体
|
|
EP4169952A4
(en)
*
|
2020-06-22 |
2025-01-29 |
Systimmune, Inc. |
Anti-trop2 antibody
|
|
CN112321715B
(zh)
*
|
2020-11-03 |
2022-05-10 |
博奥信生物技术（南京）有限公司 |
抗trop2纳米抗体及其制备方法和应用
|
|
CN114685669A
(zh)
*
|
2020-12-30 |
2022-07-01 |
和铂医药(苏州)有限公司 |
结合trop2的抗体及其用途
|
|
AU2022232548A1
(en)
*
|
2021-03-08 |
2023-10-12 |
Genequantum Healthcare (Suzhou) Co., Ltd. |
Antibody-immune agonist conjugate and applications thereof
|
|
TWI910028B
(zh)
|
2021-06-11 |
2025-12-21 |
美商基利科學股份有限公司 |
Mcl-1抑制劑與抗癌劑之組合
|
|
JP7673255B2
(ja)
|
2021-06-11 |
2025-05-08 |
ギリアード サイエンシーズ， インコーポレイテッド |
Ｍｃｌ－１阻害剤と抗体薬物コンジュゲートとの組み合わせ
|
|
CN115536747B
(zh)
*
|
2021-06-30 |
2024-08-27 |
益科思特(北京)医药科技发展有限公司 |
一种结合trop2的抗体及靶向trop2和cd3的双特异性抗体及其制备方法与应用
|
|
CN115558026A
(zh)
*
|
2021-07-02 |
2023-01-03 |
和迈生物科技有限公司 |
抗trop2单域抗体及其应用
|
|
CN118541392A
(zh)
*
|
2021-09-28 |
2024-08-23 |
准星生物医药有限公司 |
多种形式的分子复合物
|
|
US20230183216A1
(en)
|
2021-10-28 |
2023-06-15 |
Gilead Sciences, Inc. |
Pyridizin-3(2h)-one derivatives
|
|
EP4422756A1
(en)
|
2021-10-29 |
2024-09-04 |
Gilead Sciences, Inc. |
Cd73 compounds
|
|
US11814394B2
(en)
|
2021-11-16 |
2023-11-14 |
Genequantum Healthcare (Suzhou) Co., Ltd. |
Exatecan derivatives, linker-payloads, and conjugates and thereof
|
|
CN118488946A
(zh)
|
2021-12-22 |
2024-08-13 |
吉利德科学公司 |
Ikaros锌指家族降解剂及其用途
|
|
EP4452415B1
(en)
|
2021-12-22 |
2026-02-25 |
Gilead Sciences, Inc. |
Ikaros zinc finger family degraders and uses thereof
|
|
TW202340168A
(zh)
|
2022-01-28 |
2023-10-16 |
美商基利科學股份有限公司 |
Ｐａｒｐ７抑制劑
|
|
CA3253296A1
(en)
|
2022-03-17 |
2023-09-21 |
Gilead Sciences, Inc. |
Zinc Finger Degradation Agents of the Ikaros Family and Their Uses
|
|
CN119173276A
(zh)
|
2022-04-13 |
2024-12-20 |
吉利德科学公司 |
用于治疗表达Trop-2的癌症的组合疗法
|
|
US20250249115A1
(en)
|
2022-04-13 |
2025-08-07 |
Gilead Sciences, Inc. |
Combination therapy for treating tumor antigen expressing cancers
|
|
WO2023205719A1
(en)
|
2022-04-21 |
2023-10-26 |
Gilead Sciences, Inc. |
Kras g12d modulating compounds
|
|
CN117264062A
(zh)
*
|
2022-06-14 |
2023-12-22 |
上海恒润达生生物科技股份有限公司 |
一种特异性结合Trop2的抗体或其抗原结合片段及其制备方法和应用
|
|
US20240116928A1
(en)
|
2022-07-01 |
2024-04-11 |
Gilead Sciences, Inc. |
Cd73 compounds
|
|
KR20250075560A
(ko)
*
|
2022-07-15 |
2025-05-28 |
진콴텀 헬스케어 (쑤저우) 씨오., 엘티디. |
항-trop2 항체 및 이의 접합체
|
|
WO2024097812A1
(en)
|
2022-11-04 |
2024-05-10 |
Gilead Sciences, Inc. |
Therapy for treating bladder cancer
|
|
EP4638436A1
(en)
|
2022-12-22 |
2025-10-29 |
Gilead Sciences, Inc. |
Prmt5 inhibitors and uses thereof
|
|
CN118045103B
(zh)
*
|
2023-04-10 |
2025-03-14 |
英百瑞(杭州)生物医药有限公司 |
抗Trop2抗体-自然杀伤细胞偶联物及其用途
|
|
CN120882725A
(zh)
|
2023-04-11 |
2025-10-31 |
吉利德科学公司 |
Kras调节化合物
|
|
WO2024220917A1
(en)
|
2023-04-21 |
2024-10-24 |
Gilead Sciences, Inc. |
Prmt5 inhibitors and uses thereof
|
|
US20250042922A1
(en)
|
2023-06-30 |
2025-02-06 |
Gilead Sciences, Inc. |
Kras modulating compounds
|
|
AU2024297978A1
(en)
|
2023-07-26 |
2026-02-05 |
Gilead Sciences, Inc. |
Parp7 inhibitors
|
|
US20250066328A1
(en)
|
2023-07-26 |
2025-02-27 |
Gilead Sciences, Inc. |
Parp7 inhibitors
|
|
WO2025054347A1
(en)
|
2023-09-08 |
2025-03-13 |
Gilead Sciences, Inc. |
Kras g12d modulating compounds
|
|
AU2024337913A1
(en)
|
2023-09-08 |
2026-03-26 |
Gilead Sciences, Inc. |
Pyrimidine-containing polycyclic derivatives as kras g12d modulating compounds
|
|
US20250154172A1
(en)
|
2023-11-03 |
2025-05-15 |
Gilead Sciences, Inc. |
Prmt5 inhibitors and uses thereof
|
|
GB202318553D0
(en)
*
|
2023-12-05 |
2024-01-17 |
Unikum Therapeutics Aps |
Engineered plasmacytoid dendritic cells
|
|
WO2025137640A1
(en)
|
2023-12-22 |
2025-06-26 |
Gilead Sciences, Inc. |
Azaspiro wrn inhibitors
|
|
US20250376484A1
(en)
|
2024-05-21 |
2025-12-11 |
Gilead Sciences, Inc. |
Prmt5 inhibitors and uses thereof
|
|
WO2026039365A1
(en)
|
2024-08-12 |
2026-02-19 |
Gilead Sciences, Inc. |
Kras modulating compounds
|